abrdn Life Sciences Investors (HQL) vs Nuveen Multi-Asset Income Fund (NMAI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
On valuation, abrdn Life Sciences Investors trades at a lower trailing P/E (2.6x vs 5.0x for Nuveen Multi-Asset Income Fund). abrdn Life Sciences Investors pays a dividend yielding 10.52%, while Nuveen Multi-Asset Income Fund does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HQL | NMAI |
|---|---|---|
| Share price | $18.15 | $13.85 |
| Market cap | — | $462.95M |
| 1-day change | +4.13% | +1.69% |
| YTD return | +8.16% | — |
| 1-year return | +12.73% | — |
| 5-year return | -12.15% | — |
| P/E ratio (TTM) | 2.63 | 5.02 |
| EPS (TTM) | $6.91 | $2.76 |
| Dividend yield | 10.52% | 10.05% |
| Annual dividend | $1.91 | $0.00 |
| 52-week high | $22.67 | $15.06 |
| 52-week low | $15.66 | $11.99 |
| Distance from 52-week high | -19.94% | -8.03% |
| Average volume | 145.94K | 98.41K |
| Shares outstanding | — | 33.43M |
| Sector | Finance | Finance |
| Industry | Investment Managers | Investment Managers |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Nuveen Multi-Asset Income Fund trades at a higher earnings multiple (5.0x vs 2.6x trailing P/E).
About abrdn Life Sciences Investors
HQL stock →Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe.
Finance · Investment Managers
HQL vs NMAI FAQ
Which has the lower P/E ratio, HQL or NMAI?
HQL has the lower trailing P/E at 2.6, versus 5.0 for NMAI. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, abrdn Life Sciences Investors or Nuveen Multi-Asset Income Fund?
abrdn Life Sciences Investors has the higher yield at 10.52%, compared with 10.05% for Nuveen Multi-Asset Income Fund.
Are abrdn Life Sciences Investors and Nuveen Multi-Asset Income Fund in the same industry?
Yes. Both are classified in the Investment Managers industry within the Finance sector.